Two days ago, Do No Harm answered the Office of Management and Budget’s (OMB) request for comment on a proposed rule to ensure that federal funding does not support the chemical and surgical mutilation of children under 19 years of age.
Specifically, OMB proposes requiring federal agencies or pass-through entities to verify that government funds are not supporting “the so-called ‘transition’” of minors.
Do No Harm fully supports this effort.
To begin with, scientific evidence does not validate the procedures in question, which can include the use of puberty blockers, cross-sex hormones, and invasive surgeries that attempt to physically reject a child’s biological sex.
Furthermore, and consequently, funding these procedures contradicts the government’s commitment to support science-based medicine. Sex-rejecting procedures for minors are ideological, not scientific.
Finally, by directing agencies and recipients — unless expressly required by law — not to use federal awards to support “disparate-impact” studies, litigation, or related activities, the proposed rule reasonably seeks to prevent federal funding from creating race-conscious incentives in medicine. Do No Harm strongly supports this prohibition.
Please read the full comment here or below.
